About Insulet Corporation
https://www.insulet.comInsulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager.
CEO
Ashley A. McEvoy
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 708
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:8.8M
Value:$2.49B
FMR LLC
Shares:7.57M
Value:$2.14B
BLACKROCK, INC.
Shares:6.59M
Value:$1.86B
Summary
Showing Top 3 of 979
About Insulet Corporation
https://www.insulet.comInsulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $706.3M ▲ | $392.4M ▲ | $87.6M ▲ | 12.4% ▲ | $1.24 ▲ | $160.4M ▲ |
| Q2-2025 | $649.1M ▲ | $331.1M ▲ | $22.5M ▼ | 3.47% ▼ | $0.32 ▼ | $70.3M ▼ |
| Q1-2025 | $569M ▼ | $320.2M ▼ | $35.4M ▼ | 6.22% ▼ | $0.5 ▼ | $79M ▼ |
| Q4-2024 | $597.5M ▲ | $321.6M ▲ | $100.7M ▲ | 16.85% ▲ | $1.44 ▲ | $141.5M ▲ |
| Q3-2024 | $543.9M | $289M | $77.5M | 14.25% | $1.11 | $116.5M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $757.4M ▼ | $3.03B ▼ | $1.65B ▼ | $1.38B ▼ |
| Q2-2025 | $1.12B ▼ | $3.47B ▼ | $2.01B ▼ | $1.46B ▲ |
| Q1-2025 | $1.28B ▲ | $3.52B ▲ | $2.19B ▲ | $1.33B ▲ |
| Q4-2024 | $953.4M ▲ | $3.09B ▲ | $1.88B ▼ | $1.21B ▲ |
| Q3-2024 | $902.6M | $3.03B | $1.91B | $1.12B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $87.6M ▲ | $125.7M ▼ | $-31M ▼ | $-457M ▼ | $-364.2M ▼ | $104.7M ▼ |
| Q2-2025 | $22.5M ▼ | $196.5M ▲ | $-23.2M ▼ | $-343.6M ▼ | $-161.5M ▼ | $173.3M ▲ |
| Q1-2025 | $35.4M ▼ | $63.8M ▼ | $-15.7M ▲ | $277.8M ▲ | $329.7M ▲ | $51.5M ▼ |
| Q4-2024 | $100.7M ▲ | $147.7M ▲ | $-68M ▼ | $-20.9M ▼ | $50.8M ▼ | $91.7M ▲ |
| Q3-2024 | $77.5M | $98.5M | $-29.3M | $7.8M | $81.6M | $71.8M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Drug Delivery | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
 International Omnipod | $1.07Bn ▲ | $550.00M ▼ | $640.00M ▲ | $700.00M ▲ |
Revenue by Geography
| Region | Q4-2017 | Q2-2025 | Q3-2025 | Q1-2025 |
|---|---|---|---|---|
 NonUS | $40.00M ▲ | $190.00M ▲ | $200.00M ▲ | $150.00M ▼ |
 UNITED STATES | $90.00M ▲ | $460.00M ▲ | $500.00M ▲ | $420.00M ▼ |
CEO
Ashley A. McEvoy
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 708
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:8.8M
Value:$2.49B
FMR LLC
Shares:7.57M
Value:$2.14B
BLACKROCK, INC.
Shares:6.59M
Value:$1.86B
Summary
Showing Top 3 of 979